PDGFR

Catalog No.Inhibitor Name PDGFRPDGFRαPDGFRβOther
A10001Sorafenib Tosylate
**
**
Raf-1,VEGFR2/Flk1,B-Raf
A10468Imatinib Mesylate
c-Kit,v-Abl
A10880Sunitinib Malate
****
FLT3,Kit,VEGFR2
A10080Ponatinib
****
Abl,VEGFR2,FGFR1
A10103Axitinib
***
****
VEGFR1/FLT1,VEGFR2/Flk1,VEGFR3
A10259Imatinib
**
c-Kit,v-Abl
A10137Nintedanib
**
**
VEGFR3,VEGFR2,LCK
A10699Pazopanib HCl
**
VEGFR1,VEGFR2,VEGFR3
A11411Dovitinib
*
***
FLT3,c-Kit,FGFR1
A10025Linifanib
**
VEGFR1/FLT1,CSF-1R,FLT3
A11052Crenolanib
****
****
A10558Masitinib
*
*
Kit,Lyn B,Abl1
A10101Tivozanib
***
**
VEGFR2,VEGFR3,EphB2
A10610Amuvatinib
***
c-Kit (D816H),FLT3 (D835Y)
A10608Motesanib Diphosphate
**
VEGFR1,VEGFR2,VEGFR3
A10953Orantinib
***
FGFR1,Flk1
A11350CP-673451
***
****
c-Kit,VEGFR2,VEGFR1
A10502Ki8751
**
VEGFR2,c-Kit,FGFR2
A10903Telatinib
***
c-Kit,VEGFR3,VEGFR2
A11207PP121
****
Hck,VEGFR,mTOR
A11518Pazopanib
**
VEGFR1,VEGFR2,VEGFR3
A10504KRN 633
*
*
VEGFR3,VEGFR2,VEGFR1
A10198Dovitinib Dilactic Acid
*
***
FLT3,c-Kit,VEGFR3/FLT4
A11753MK-2461
***
c-Met (M1250T),c-Met (Y1235D),c-Met (Y1230H)
A14156AZD2932
****
Flt3,VEGFR-2,c-Kit
A15062DCC-2618
***
***
c-Kit

Notes:
1.Hover mouse over " * " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " * " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.

7 个项目

每页

设置降序顺序
  1. TAK-593

    Catalog No. A13555
    Quick View
    VEGFR/PDGFR 抑制剂
    TAK-5933是一种口服制剂,其中含有血管内皮生长因子受体(VEGFR)和血小板衍生生长因子受体(PDGFR)的小分子受体酪氨酸激酶抑制剂,具有潜在的抗肿瘤活性。 了解更多
  2. Dovitinib Dilactic acid (TKI258 Dilactic acid)

    Catalog No. A10198
    Quick View
    RTK 抑制剂
    Dovitinib是一种小分子多靶点酪氨酸激酶抑制剂,可抑制通过ZNF198-FGFR1或BCR-FGFR1转化为IL3独立性的Ba / F3细胞,IC50值分别为150 nM和90 nM。 了解更多
  3. N-Desethyl Sunitinib

    Catalog No. A15182
    Quick View
    VEGFR/PDGFRβ/KIT 抑制剂
    N-Desethyl Sunitinib是舒尼替尼的主要药理活性代谢产物,是有效的,ATP竞争性VEGFR,PDGFRβ和KIT抑制剂(VEGFR -1,-2,-3的Ki值为2、9、17、8和4 nM。分别为PDGFRβ和KIT)。 了解更多
  4. Regorafenib monohydrate

    Catalog No. A15218
    Quick View
    Tyrosine kinase 抑制剂
    Regorafenib monohydrate是VEGFR1/VEGFR2/VEGFR3/PDGFRβ/Kit/RET和Raf-1的多靶点抑制剂,IC50分别为13 nM/4.2 nM/46 nM/22 nM/7 nM/1.5 nM和2.5 nM。 了解更多
  5. Nintedanib esylate

    Catalog No. A16197
    Quick View
    RTK 抑制剂
    Nintedanib esylate是多种受体酪氨酸激酶(RTK)和非受体酪氨酸激酶(nRTK)的有效抑制剂。 了解更多
  6. Pazopanib (GW-786034)

    Catalog No. A11518
    Quick View
    VEGFR 抑制剂
    Pazopanib (GW-786034)是VEGFR-1,VEGFR-2,VEGFR-3,PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂,可阻止肿瘤生长并抑制血管生成。 了解更多
  7. Sorafenib Tosylate (Nexavar)

    Catalog No. A10001
    Quick View
    Raf 抑制剂
    Sorafenib Tosylate (Nexavar)是几种酪氨酸蛋白激酶(VEGFR和PDGFR)和RAF/MEK/ERK级联抑制剂的新型小分子抑制剂,Raf-1,wt BRAF和V599E突变型BRAF的IC50为6、22、38 nM。 了解更多

7 个项目

每页

设置降序顺序
Rewards